MrTaimurShah

Faculty of Medicine, Department of Surgery & Cancer

Clinical Senior Lecturer

Contact

Location

Charing Cross HospitalCharing Cross Campus

Summary

Mr Taimur T. Shah is a Clinical Senior Lecturer and Consultant Urologist at Imperial College London (ICL). He has a sub-specialist interest in prostate cancer diagnostics, imaging, Robotic surgery, Focal Therapy (High Intensity Focused Ultrasound and Cryotherapy) for prostate cancer and minimally invasive treatments for Benign Prostatic Hyperplasia (BPH). He has published extensively in peer-reviewed journals within these fields and been invited to give presentations nationally and internationally.

Mr Shah qualified from University College London (UCL) where he was also awarded a First-Class Honours degree in Molecular Medicine. He subsequently completed his urological training in the London Deanery rotating through the Charing Cross Hospital, The Royal Marsden Hospital, Barnet and Chase Farm Hospitals and the Whittington Hospital. He subsequently undertook a uro-oncology fellowship in robotic surgery at Guys and St Thomas' hospital.

He has a PhD from University College London (UCL) into focal therapy for newly diagnosed prostate cancer and cancer that has recurred after previous radiotherapy. He has helped design and deliver multiple clinical trials for primary, metastatic and radio-recurrent prostate cancer and is currently part of the Imperial Prostate (IP) Group at Imperial College London (ICL).

He has been an advocate for collaborative and also trainee led research and previously spent 5-years as vice chair of the British Urology Researchers in Surgical Training (BURST) research collaborative.

Publications

Journals

Reddy D, van Son M, Peters M, et al.Reddy D, van Son M, Peters M, Tanaka MB, Dudderidge T, Cullen E, Ho CLT, Hindley RG, Emara A, Mccracken S, Orczyk C, Shergill I, Mangar S, Nigam R, Virdi J, Moore CM, Arya M, Shah TT, Winkler M, Emberton M, Falconer A, Belsey J, Ahmed HU close, 2023, Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis, Journal of Medical Economics, Vol:26, ISSN:1369-6998, Pages:1099-1107

Deivasigamani S, Kotamarti S, Rastinehad AR, et al.Deivasigamani S, Kotamarti S, Rastinehad AR, Salas RS, de la Rosette JJMCH, Lepor H, Pinto P, Ahmed HU, Gill I, Klotz L, Taneja SS, Emberton M, Lawrentschuk N, Wysock J, Feller JF, Crouzet S, Kumar M P, Seguier D, Adams ES, Michael Z, Abreu A, Jack Tay K, Ward JF, Shinohara K, Katz AE, Villers A, Chin JL, Stricker PD, Baco E, Macek P, Ahmad AE, Chiu PKF, Crawford ED, Rogers CG, Futterer JJ, Rais-Bahrami S, Robertson CN, Hadaschik B, Marra G, Valerio M, Chong KT, Kasivisvanathan V, Tan WP, Lomas D, Walz J, Guimaraes GC, Mertziotis NI, Becher E, Finelli A, Kasraeian A, Lebastchi AH, Vora A, Rosen MA, Bakir B, Arcot R, Yee S, Netsch C, Meng X, de Reijke TM, Tan YG, Regusci S, Benjamin TGR, Olivares R, Noureldin M, Bianco FJ, Sivaraman A, Kim FJ, Given RW, Dason S, Sheetz TJ, Shoji S, Schulman A, Royce P, Shah TT, Scionti S, Salomon G, Laguna P, Tourinho-Barbosa R, Aminsharifi A, Cathelineau X, Gontero P, Stabile A, Grummet J, Ledbetter L, Graton M, Stephen Jones J, Polascik TJ, Focal Therapy Society close, 2023, Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement., Eur Urol, Vol:84, Pages:547-560

Light A, Kanthabalan A, Otieno M, et al.Light A, Kanthabalan A, Otieno M, Pavlou M, Omar R, Adeleke S, Giganti F, Brew-Graves C, Williams NR, Emara A, Haroon A, Latifoltojar A, Sidhu H, Freeman A, Orczyk C, Nikapota A, Dudderidge T, Hindley RG, Virdi J, Arya M, Payne H, Mitra AV, Bomanji J, Winkler M, Horan G, Moore CM, Emberton M, Punwani S, Ahmed HU, Shah TT close, 2023, The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial., Eur Urol

Mayor N, Eldred-Evans D, Tam H, et al.Mayor N, Eldred-Evans D, Tam H, Sokhi H, Padhani AR, Connor MJ, Price D, Gammon M, Klimowska-Nassar N, Burak P, Day E, Winkler M, Fiorentino F, Shah T, Ahmed HU close, 2023, Prostagram magnetic resonance imaging in a screening population: Prostate Imaging-Reporting and Data System or Likert?, Bju Int

Light A, Li X, Otieno M, et al.Light A, Li X, Otieno M, Ahmed HU, Shah TT close, 2023, The 'Leucocyte Coping Capacity' test for identifying radiorecurrent prostate cancer: a pilot study, Bju International, ISSN:1464-4096

More Publications